SCHEMBL1668346

SCHEMBL1668346

Nc1c(-c2ccccc2)ccc2cccc(S(=O)(=O)O)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 2/20 0.49
FABP4 P15090 1/20 0.49
CCNA2 P20248 1/20 0.49
CDK2 P24941 1/20 0.49
MAPK14 Q16539 1/20 0.49
NR4A1 P22736 1/20 0.48
SNCA P37840 3/20 0.43
CHAT P28329 1/20 0.43
SENP2 Q9HC62 3/20 0.37
SENP1 Q9P0U3 3/20 0.37
SUMO2 P61956 2/20 0.37
SUMO1 P63165 2/20 0.37
SENP7 Q9BQF6 2/20 0.37
ENPP2 Q13822 1/20 0.36
F2 P00734 1/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
MAPT P10636 3/20 0.35
ALDH1A1 P00352 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31490474 0.82 TTR (0.55) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL11158822 0.82 TTR (0.55) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL1143477 0.80 TTR (0.46) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL1755221 0.80 TTR (0.49) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL9275088 0.79 TTR (0.49) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL9464970 0.78 CDK2 (0.46) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL28349046 0.77 MAPT (0.41) TTRSNCACHATSENP2SENP1
SCHEMBL28293324 0.76 ALDH1A1 (0.46) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL1742117 0.74 TTR (0.59) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL179823 0.73 TTR (0.58) TTRFABP4CCNA2CDK2MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3427183-A1 METHOD OF CURVILINEAR SIGNAL DETECTION AND ANALYSIS AND ASSOCIATED PLATFORM Genomic Vision (FR) 2019-01-16 EP disclosed
EP-3427171-A1 METHOD FOR ANALYZING A SEQUENCE OF TARGET REGIONS AND DETECT ANOMALIES Genomic Vision (FR) 2019-01-16 EP disclosed
EP-2702172-A1 METHOD FOR DETERMINING CLINICALLY RELEVANT HYPOXIA IN CANCER Overgaard, Jens (DK) 2014-03-05 EP disclosed
WO-2012146259-A1 METHOD FOR DETERMINING CLINICALLY RELEVANT HYPOXIA IN CANCER OVERGAARD JENS (DK) 2012-11-01 WO disclosed
WO-2011044902-A1 TFF3 HYPOMETHYLATION AS A NOVEL BIOMARKER FOR PROSTATE CANCER AARHUS UNIVERSITET (DK) 2011-04-21 WO disclosed
EP-2069528-A2 A METHOD FOR DIAGNOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36 Aarhus Universitet (DK) 2009-06-17 EP disclosed
WO-2008095492-A2 A METHOD FOR DIAGNOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36 AARHUS UNIVERSITET (DK) 2008-08-14 WO disclosed
WO-2007070553-A2 DOUBLE-TILED AND MULTI-TILED ARRAYS AND METHODS THEREOF THE JOHNS HOPKINS UNIVERSITY (US) 2007-06-21 WO disclosed
EP-1583972-A2 CAPTURE COMPOUNDS, COLLECTIONS THEREOF AND METHODS FOR ANALYZING THE PROTEOME AND COMPLEX COMPOSITIONS HK Pharmaceuticals, Inc. (US) 2005-10-12 EP disclosed
EP-1412729-A4 MICROFLUIDIC SYSTEM INCLUDING A VIRTUAL WALL FLUID INTERFACE PORT FOR INTERFACING FLUIDS WITH THE MICROFLUIDIC SYSTEM CYTONOME INC (US) 2005-03-09 EP disclosed
WO-2004064972-A9 CAPTURE COMPOUNDS, COLLECTIONS THEREOF AND METHODS FOR ANALYZING THE PROTEOME AND COMPLEX COMPOSITIONS HK PHARMACEUTICALS INC (US) 2004-09-16 WO disclosed
WO-2004064972-A2 CAPTURE COMPOUNDS, COLLECTIONS THEREOF AND METHODS FOR ANALYZING THE PROTEOME AND COMPLEX COMPOSITIONS HK PHARMACEUTICALS, INC. (US) 2004-08-05 WO disclosed
EP-1412729-A2 MICROFLUIDIC SYSTEM INCLUDING A VIRTUAL WALL FLUID INTERFACE PORT FOR INTERFACING FLUIDS WITH THE MICROFLUIDIC SYSTEM Cytonome, Inc. (US) 2004-04-28 EP disclosed
WO-2003000416-A2 MICROFLUIDIC SYSTEM INCLUDING A VIRTUAL WALL FLUID INTERFACE PORT FOR INTERFACING FLUIDS WITH THE MICROFLUIDIC SYSTEM TERAGENICS, INC. (US) 2003-01-03 WO disclosed
WO-2003000418-A2 MICROFLUIDIC SYSTEM INCLUDING A VIRTUAL WALL FLUID INTERFACE PORT FOR INTERFACING FLUIDS WITH THE MICROFLUIDIC SYSTEM CYTONOME, INC. (US) 2003-01-03 WO disclosed
WO-2003000417-A2 MICROFLUIDIC SYSTEM INCLUDING A VIRTUAL WALL FLUID INTERFACE PORT FOR INTERFACING FLUIDS WITH THE MICROFLUIDIC SYSTEM CYTONOME, INC. (US) 2003-01-03 WO disclosed